pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

5,172 catalysts · 4,686 phase readout · 2,347 8k filing · 285 earnings · 201 pdufa · 172 phase 2 completion · 73 phase 1 completion

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-20: 0 catalysts2026-07-21: 0 catalysts2026-07-22: 14 catalysts2026-07-23: 2 catalysts2026-07-24: 1 catalyst2026-07-25: 0 catalysts2026-07-26: 0 catalysts2026-07-27: 2 catalysts2026-07-28: 4 catalysts2026-07-29: 12 catalysts2026-07-30: 12 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 0 catalysts2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: earnings×type: phase readout×type: pdufa×clear all
type
  • phase readout4,686
  • 8k filing2,347
  • earnings285
  • pdufa201
  • phase 2 completion172
  • phase 1 completion73
phase 2 initiation
62
  • phase 1 initiation40
  • phase 1 2 completion35
  • phase 0 trial completion23
  • therapy area
    • Dermatology1
    • Infectious Disease1

    Date TBD

    50
    ›RECRUITINGphase readoutNCT07320209: Physiological and Neurocognitive Responses to Multisensory Food Cues in VR

    Sponsor: Marmara University. Phase: NA. Conditions: Healthy Participants

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07609732: Outcomes of Conventional Root Canal Treatment Compared to Regenerative Endodontics, and Cleaning and Shaping Only in Mature Upper First Premolars

    Sponsor: Ain Shams University. Phase: NA. Conditions: Regenerative Endodontic Treatment, Cleaning and Shaping Only With Proper Coronal Seal, Necrotic Mature First Premolar

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07398898: Use of Augmented Reality Glasses and Noise-Cancelling Headphones to Reduce Dental Anxiety in Adult Patients

    Sponsor: Medical University of Warsaw. Phase: NA. Conditions: Dental Anxiety, Music Therapy, Oral Surgical Procedures

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07424963: Hepatic Venous Pressure Gradient Versus Endoscopic Ultrasound-Guided Portal Pressure Gradient - Comparative Analysis (HEPCA)

    Sponsor: Military University Hospital, Prague. Phase: NA. Conditions: Cirrhosis, Portal Hypertension, EUS, Non-Cirrhotic Portal Hypertension, HVPG, Hepatic Venous Pressure Gradient

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT03571763: The Impact of Anti-thrombosis on Cerebral Microbleeds and Intracranial Hemorrhage in Ischemic Stroke Patients

    Sponsor: General Hospital of Shenyang Military Region. Phase: . Conditions: Ischemic Stroke

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05352893: Study to Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in the Treatment of Subjects With GPP

    Sponsor: Vanda Pharmaceuticals. Phase: PHASE3. Conditions: Generalized Pustular Psoriasis

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT02641093: Phase II Trial of Adjuvant Cisplatin and Radiation With Pembrolizumab in Resected Head and Neck Squamous Cell Carcinoma

    Sponsor: Trisha Wise-Draper. Phase: PHASE2. Conditions: Head and Neck Cancer

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07334821: Diagnostic Performance of PIC Cystogram vs VCUG in Children

    Sponsor: Tarik Emre Sener. Phase: NA. Conditions: Pediatric Urology

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07494721: Effects of Training With a Pressure Cuff on Cellular Energy Activity

    Sponsor: Spital Thurgau AG. Phase: NA. Conditions: Physical Deconditioning

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05425316: Speech in Hepatic Encephalopathy (HE)

    Sponsor: University of Michigan. Phase: . Conditions: Hepatic Encephalopathy

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT01787500: Vemurafenib, Cetuximab, and Irinotecan Hydrochloride in Treating Patients With Solid Tumors That Are Metastatic or That Cannot Be Removed by Surgery

    Sponsor: M.D. Anderson Cancer Center. Phase: PHASE1. Conditions: BRAF NP_004324.2:p.V600X, KRAS wt Allele, Metastatic Malignant Solid Neoplasm, Stage IV Colorectal Cancer AJCC v7, Stage IVA Colorectal Cancer AJCC v7, Stage IVB Colorectal Cancer AJCC v7, Unresectable Solid Neoplasm

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT04739800: Comparison of Standard of Care Treatment With a Triplet Combination of Targeted Immunotherapeutic Agents

    Sponsor: National Cancer Institute (NCI). Phase: PHASE2. Conditions: Fallopian Tube Mucinous Adenocarcinoma, Ovarian Seromucinous Carcinoma, Platinum-Refractory Fallopian Tube Carcinoma, Platinum-Refractory Ovarian Carcinoma, Platinum-Refractory Primary Peritoneal Carcinoma, Recurrent Fallopian Tube Clear Cell Adenocarcinoma, Recurrent Fallopian Tube Endometrioid Adenocarcinoma, Recurrent Fallopian Tube High Grade Serous Adenocarcinoma, Recurrent Fallopian Tube Mucinous Adenocarcinoma, Recurrent Fallopian Tube Transitional Cell Carcinoma, Recurrent Fallopian Tube Undifferentiated Carcinoma, Recurrent Low Grade Fallopian Tube Serous Adenocarcinoma, Recurrent Ovarian Clear Cell Adenocarcinoma, Recurrent Ovarian Endometrioid Adenocarcinoma, Recurrent Ovarian High Grade Serous Adenocarcinoma, Recurrent Ovarian Low Grade Serous Adenocarcinoma, Recurrent Ovarian Mucinous Adenocarcinoma, Recurrent Ovarian Seromucinous Carcinoma, Recurrent Ovarian Transitional Cell Carcinoma, Recurrent Ovarian Undifferentiated Carcinoma, Recurrent Platinum-Resistant Fallopian Tube Carcinoma, Recurrent Platinum-Resistant Ovarian Carcinoma, Recurrent Platinum-Resistant Primary Peritoneal Carcinoma, Recurrent Primary Peritoneal Clear Cell Adenocarcinoma, Recurrent Primary Peritoneal Endometrioid Adenocarcinoma, Recurrent Primary Peritoneal High Grade Serous Adenocarcinoma, Recurrent Primary Peritoneal Low Grade Serous Adenocarcinoma, Recurrent Primary Peritoneal Transitional Cell Carcinoma, Recurrent Primary Peritoneal Undifferentiated Carcinoma, Refractory Fallopian Tube Clear Cell Adenocarcinoma, Refractory Fallopian Tube Endometrioid Adenocarcinoma, Refractory Fallopian Tube High Grade Serous Adenocarcinoma, Refractory Fallopian Tube Mucinous Adenocarcinoma, Refractory Fallopian Tube Transitional Cell Carcinoma, Refractory Fallopian Tube Undifferentiated Carcinoma, Refractory Low Grade Fallopian Tube Serous Adenocarcinoma, Refractory Ovarian Clear Cell Adenocarcinoma, Refractory Ovarian Endometrioid Adenocarcinoma, Refractory Ovarian High Grade Serous Adenocarcinoma, Refractory Ovarian Low Grade Serous Adenocarcinoma, Refractory Ovarian Mucinous Adenocarcinoma, Refractory Ovarian Seromucinous Carcinoma, Refractory Ovarian Transitional Cell Carcinoma, Refractory Ovarian Undifferentiated Carcinoma, Refractory Primary Peritoneal Clear Cell Adenocarcinoma, Refractory Primary Peritoneal Endometrioid Adenocarcinoma, Refractory Primary Peritoneal High Grade Serous Adenocarcinoma, Refractory Primary Peritoneal Low Grade Serous Adenocarcinoma, Refractory Primary Peritoneal Transitional Cell Carcinoma, Refractory Primary Peritoneal Undifferentiated Carcinoma

    ›COMPLETEDphase readoutNCT06733207: Pupillometry Use & Professional's Inspection : Leveling Subjectivity

    Sponsor: CHU de Reims. Phase: . Conditions: Intensive Care, Pupil Assessment, Pupillometry, Neurological Examination, Clinical Competence, Nursing Assessment, Diagnostic Techniques and Procedures, Comparative Effectiveness Research, Interprofessional Relations, Observer Variation

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07237607: Developing an Artificial Intelligence (AI) Chatbot for Adolescents and Young Adults With Eating Disorders

    Sponsor: Milton S. Hershey Medical Center. Phase: NA. Conditions: Eating Disorders, Anorexia Nervosa, Bulimia Nervosa, Binge-Eating Disorder

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07170592: A Phase 1 Study of OTS-412 (Recombinant Oncolytic Vaccinia Virus) in Treatment-refractory Solid Tumor Patients

    Sponsor: Bionoxx Inc.. Phase: PHASE1. Conditions: Treatment-Refractory Solid Tumors

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07621692: Exploring Auger-Enhanced PSMA-Targeted Radioligand Therapy: A First-in-Taiwan Clinical Study of 161Tb-PSMA-I&T

    Sponsor: National Taiwan University Hospital. Phase: PHASE1. Conditions: Metastatic Castration Resistant Prostate Cancer (mCRPC)

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07257692: Effect of Feeding Status on Appetite and Eating Behaviour.

    Sponsor: University of Glasgow. Phase: NA. Conditions: Healthy

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07058792: Impact of Medjool Date Consumption on Labor and Delivery Outcomes

    Sponsor: The Cleveland Clinic. Phase: NA. Conditions: Spontaneous Labor

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05258292: Glycemic Variations During the Menstrual Cycle in Women With Type 1 Diabetes

    Sponsor: Institut de Recherches Cliniques de Montreal. Phase: . Conditions: Type1diabetes

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06733636: Scents of Progress: Leveraging a Novel Device for Olfactory Training in Older Adults

    Sponsor: Johns Hopkins University. Phase: NA. Conditions: Olfactory Dysfunction, Smell Loss, Anosmia, Hyposmia

    full page →ctgov ↗
    ›TERMINATEDphase readoutNCT05710536: Safety and Efficacy of Formulation for Improving Vagina Laxity: A Pilot Study

    Sponsor: USMARI Research & Innovation Centre. Phase: NA. Conditions: Healthy

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06662136: The Effect of Motivational Interviewing on HPV-DNA Testing

    Sponsor: Muazez küçükkaya. Phase: NA. Conditions: Cervical Cancers

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07521436: Awareness of Risk Factors and Perception of Cardiovascular Risk in Secondary Prevention Among Women and Men

    Sponsor: Istituti Clinici Scientifici Maugeri SpA. Phase: . Conditions: Cardiovascular Disease

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06813911: Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD

    Sponsor: Novartis Pharmaceuticals. Phase: PHASE3. Conditions: Atherosclerotic Cardiovascular Disease (ASCVD)

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06608511: Liquid Biomarker Study in Melanoma and Non-Melanoma Skin Cancers

    Sponsor: University of Wisconsin, Madison. Phase: . Conditions: Skin Cancer, Melanoma (Skin Cancer), Basal Cell Carcinoma of Skin, Basal Cell Carcinoma of Skin, Site Unspecified, Cutaneous Squamous Cell Carcinoma (CSCC), Merkel Cell Carcinoma of Skin

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07377071: Folate Treatment to Reduce Death Risk in the Year After Infection-Related Acute Kidney Injury

    Sponsor: The University of Hong Kong. Phase: EARLY_PHASE1. Conditions: Infection-Associated Acute Kidney Injury

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05640271: Tocilizumab for Acute Chest Syndrome

    Sponsor: University of Chicago. Phase: PHASE2. Conditions: Sickle Cell Disease, Acute Chest Syndrome

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07585344: Interrupted 'Figure-of-X' Versus Continuous Suturing Technique for Abdominal Wall Closure in Colorectal Laparotomies

    Sponsor: Islamabad Medical and Dental College. Phase: NA. Conditions: Colorectal Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06801834: Study of Sacituzumab Govitecan Versus Standard of Care in Participants With Previously Treated Extensive Stage Small Cell Lung Cancer

    Sponsor: Gilead Sciences. Phase: PHASE3. Conditions: Extensive Stage Small Cell Lung Cancer (ES-SCLC)

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04967664: Comparison of Qutenza (8% Capsaicin) With a Low-dose Capsaicin for Treatment of Nerve Pain After Surgery

    Sponsor: Averitas Pharma, Inc.. Phase: PHASE3. Conditions: Post Surgical Neuropathic Pain

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07571109: AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea

    Sponsor: Novo Nordisk A/S. Phase: PHASE3. Conditions: Obesity, Overweight, Obstructive Sleep Apnoea

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07371871: A Prospective, Single-arm, Exploratory Study of Trifluridine/Tipiracil (TAS-102) Combined With Apatinib as Third-line Therapy for Advanced Gastric Cancer

    Sponsor: Anhui Provincial Cancer Hospital. Phase: NA. Conditions: Advanced Gastric Cancer

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07544498: XR2ESILIENCE - XR-Based Resilience Training for Stress and Mental Health in Healthcare Workers

    Sponsor: Medical University of Graz. Phase: NA. Conditions: Occupational Stress, Work-Related Stress, Mental Health, Burnout, Resilience

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07565298: Adding Group-Based Pain Neuroscience Education to a Community Exercise Program for Older Women With Knee Osteoarthritis

    Sponsor: Pontificia Universidad Catolica de Chile. Phase: NA. Conditions: Knee Osteoarthritis, Older Women, Pain, Disability

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT07381998: Effects of Total Thyroid Removal on Parathyroid Function and Quality of Life

    Sponsor: Aarhus University Hospital. Phase: NA. Conditions: Hypoparathyroidism Post-surgical, Quality of Life

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06958198: A Study to Assess the Experimental Malaria Vaccines R78C and RH5.1 Combined With R21/Matrix-M (a "Multi-stage" Malaria Vaccine)

    Sponsor: University of Oxford. Phase: PHASE1. Conditions: Malaria,Falciparum

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07601698: Dexmedetomidine vs Propofol-lidocaine Mixture in Preventing the Post Operative Emergence Agitation Following Sevoflurane Anasthesia

    Sponsor: Sohag University. Phase: PHASE4. Conditions: Emergence Agitation

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07441863: Structured Pulmonary Physiotherapy After Lung Cancer Surgery by Age Group

    Sponsor: Bezmialem Vakif University. Phase: NA. Conditions: Lung Cancer, Postoperative Pulmonary Complications

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07518563: Neural Synchronization During Gesture Production and Comprehension in Individuals With Aphasia and Healthy Controls: A Study Using EEG Hyperscanning

    Sponsor: IRCCS San Camillo, Venezia, Italy. Phase: . Conditions: Aphasia, Stroke, Gestures

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT01328587: Eltrombopag for Moderate Aplastic Anemia

    Sponsor: National Heart, Lung, and Blood Institute (NHLBI). Phase: PHASE2. Conditions: Moderate Aplastic Anemia, Unilineage Bone Marrow Failure Disorders

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT01008787: Motivational Interviewing for Physical Activity

    Sponsor: M.D. Anderson Cancer Center. Phase: NA. Conditions: Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07096193: Study of GS-4321 in Healthy Participants and Participants With Chronic Hepatitis Delta Virus

    Sponsor: Gilead Sciences. Phase: PHASE1. Conditions: Chronic Hepatitis Delta

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07561593: Improving Health Outcomes Through Investigations of Wabanaki Food Systems in Maine

    Sponsor: Wabanaki Public Health and Wellness. Phase: NA. Conditions: Food Insecurity

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07483593: Baseline Gastric Volume in Diabetic vs Non-Diabetic Patients

    Sponsor: Kocaeli University. Phase: . Conditions: Gastric Volume, Preoperative Fasting, Diabetes Mellitus

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07505914: Effects of Breathing Exercises on Cognition in Older Adults

    Sponsor: Istanbul University - Cerrahpasa. Phase: NA. Conditions: Older Adults (65 Years and Older), Cognition, Balance Control in Elderly, Fall Prevention in Healthy Aging

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07578714: Core Stability, Postural Balance, and Flexibility in Healthy Women: A Comparative Study Between Pilates Practitioners and Sedentary Individuals

    Sponsor: Istinye University. Phase: . Conditions: Core Stability, Postural Balance, Pilates, Core Stability, Pilates, Healthy Life Style

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07591116: Intertransverse Process Block Versus External Oblique Intercostal Plane Block After Laparoscopic Sleeve Gastrectomy

    Sponsor: Antalya City Hospital. Phase: NA. Conditions: Intertransverse Process Block, External Oblique Intercostal Plane Block, Sleeve Gastrectomy, Regional Anaesthesia, Postoperative Pain

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05811416: A Study to Describe the Persistence With Ozanimod Treatment in Relapsing-Remitting Multiple Sclerosis (RRMS) Participants

    Sponsor: Bristol-Myers Squibb. Phase: . Conditions: Relapsing-remitting Multiple Sclerosis (RRMS)

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06473506: Group A Streptococcus Saliva Study

    Sponsor: The Hospital for Sick Children. Phase: NA. Conditions: Group A Streptococcal Infections

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07192406: Cross-cultural Adaptation of the Toxic Masculinity Scale Among Indonesian Nursing Students: A Psychometric Testing

    Sponsor: Kaohsiung Medical University. Phase: . Conditions: Masculinity, Nursing, Scale Reliability Validity, Student

    full page →ctgov ↗
    ← prev
    page 54 of 104
    next →
    full page →ctgov ↗